Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5699354 | Clinical Oncology | 2010 | 5 Pages |
Abstract
Most of the clinicians followed up their patients up to a minimum of 5 years, with a significant minority who followed up the patients treated for cancers of the head and neck for longer periods. More studies are needed to elucidate the rationale and evidence for follow-up and to determine the adequate period of surveillance.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A. Joshi, F. Calman, M. O'Connell, J.-P. Jeannon, P. Pracy, R. Simo,